Prevest Denpro Share Price
Sector: Medical Equipment & Supplies
477.85 +0.70 (0.15%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
473.05
Today’s High
479.90
52 Week Low
393.60
52 Week High
686.00
Key Metrics
- Market Cap (In Cr) 573.74
- Beta 2.17
- Div. Yield (%) 0
- P/B 5.42
- TTM P/E 28.35
- Peg Ratio 1.95
- Sector P/E 41.08
- D/E 0
- Open Price 478
- Prev Close 477.15
Prevest Denpro Analysis
Price Analysis
-
1 Week-0.39%
-
3 Months11.41%
-
6 Month-15.85%
-
YTD-19%
-
1 Year-3.22%
Risk Meter
- 52% Low risk
- 52% Moderate risk
- 52% Balanced Risk
- 52% High risk
- 52% Extreme risk
Prevest Denpro News
Prevest Denpro reports 35% rise in Q4 PAT, Board gets new members to drive future growth
1 min read . 08 May 2023This healthcare stock gains 13% after 35.80% jump in Q4 PAT and 30.60% growth in
1 min read . 28 Apr 2023Multibagger IPO: This BSE SME issue gives 275% return to allottees in 3 months
2 min read . 27 Dec 2021Prevest Denpro Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 63.03
- Selling/ General/ Admin Expenses Total
- 11.35
- Depreciation/ Amortization
- 1.9
- Other Operating Expenses Total
- 17.34
- Total Operating Expense
- 42.84
- Operating Income
- 20.18
- Net Income Before Taxes
- 24.25
- Net Income
- 18.16
- Diluted Normalized EPS
- 15.13
- Period
- 2025
- Total Assets
- 112.53
- Total Liabilities
- 6.96
- Total Equity
- 105.57
- Tangible Book Valueper Share Common Eq
- 87.95
- Period
- 2025
- Cashfrom Operating Activities
- 14.82
- Cashfrom Investing Activities
- -1.33
- Cashfrom Financing Activities
- -1.2
- Net Changein Cash
- 12.29
- Period
- 2024
- Total Revenue
- 56.43
- Selling/ General/ Admin Expenses Total
- 14.4
- Depreciation/ Amortization
- 1.28
- Other Operating Expenses Total
- 8.29
- Total Operating Expense
- 37.86
- Operating Income
- 18.57
- Net Income Before Taxes
- 21.43
- Net Income
- 16.14
- Diluted Normalized EPS
- 13.44
- Period
- 2024
- Total Assets
- 94.82
- Total Liabilities
- 6.2
- Total Equity
- 88.62
- Tangible Book Valueper Share Common Eq
- 73.83
- Period
- 2024
- Cashfrom Operating Activities
- 11.62
- Cashfrom Investing Activities
- -1.7
- Cashfrom Financing Activities
- -0.32
- Net Changein Cash
- 9.61
- Period
- 2023
- Total Revenue
- 49.85
- Selling/ General/ Admin Expenses Total
- 8.19
- Depreciation/ Amortization
- 0.68
- Other Operating Expenses Total
- 9.46
- Total Operating Expense
- 30.93
- Operating Income
- 18.92
- Net Income Before Taxes
- 20.96
- Net Income
- 15.71
- Diluted Normalized EPS
- 13.09
- Period
- 2023
- Total Assets
- 78.61
- Total Liabilities
- 5.81
- Total Equity
- 72.8
- Tangible Book Valueper Share Common Eq
- 60.65
- Period
- 2023
- Cashfrom Operating Activities
- 10.41
- Cashfrom Investing Activities
- -12.38
- Cashfrom Financing Activities
- -1.37
- Net Changein Cash
- -3.33
- Period
- 2022
- Total Revenue
- 37.62
- Selling/ General/ Admin Expenses Total
- 6.52
- Depreciation/ Amortization
- 0.52
- Other Operating Expenses Total
- 6.75
- Total Operating Expense
- 23.58
- Operating Income
- 14.04
- Net Income Before Taxes
- 16.05
- Net Income
- 11.57
- Diluted Normalized EPS
- 9.64
- Period
- 2022
- Total Assets
- 64.16
- Total Liabilities
- 7.05
- Total Equity
- 57.1
- Tangible Book Valueper Share Common Eq
- 47.58
- Period
- 2022
- Cashfrom Operating Activities
- 6.96
- Cashfrom Investing Activities
- -3.87
- Cashfrom Financing Activities
- 22.82
- Net Changein Cash
- 25.91
- Period
- 2020
- Total Revenue
- 22.77
- Selling/ General/ Admin Expenses Total
- 4.62
- Depreciation/ Amortization
- 0.55
- Other Operating Expenses Total
- 6.04
- Total Operating Expense
- 18.2
- Operating Income
- 4.57
- Net Income Before Taxes
- 6.14
- Net Income
- 5.12
- Diluted Normalized EPS
- 4.26
- Period
- 2020
- Total Assets
- 21.05
- Total Liabilities
- 6.43
- Total Equity
- 14.61
- Tangible Book Valueper Share Common Eq
- 12.17
- Period
- 2020
- Cashfrom Operating Activities
- 4.92
- Cashfrom Investing Activities
- -0.76
- Cashfrom Financing Activities
- 0.05
- Net Changein Cash
- 4.21
- Period
- 2019
- Total Revenue
- 19.28
- Selling/ General/ Admin Expenses Total
- 3.57
- Depreciation/ Amortization
- 0.47
- Other Operating Expenses Total
- 5.41
- Total Operating Expense
- 15.94
- Operating Income
- 3.34
- Net Income Before Taxes
- 3.69
- Net Income
- 2.9
- Diluted Normalized EPS
- 2.42
- Period
- 2019
- Total Assets
- 13.2
- Total Liabilities
- 3.7
- Total Equity
- 9.5
- Tangible Book Valueper Share Common Eq
- 7.91
- Period
- 2019
- Cashfrom Operating Activities
- 3.17
- Cashfrom Investing Activities
- -1.4
- Cashfrom Financing Activities
- 0.1
- Net Changein Cash
- 1.88
- Period
- 2018
- Total Revenue
- 17
- Selling/ General/ Admin Expenses Total
- 3.35
- Depreciation/ Amortization
- 0.47
- Other Operating Expenses Total
- 5.31
- Total Operating Expense
- 14.42
- Operating Income
- 2.58
- Net Income Before Taxes
- 3.03
- Net Income
- 2.6
- Diluted Normalized EPS
- 2.16
- Period
- 2018
- Total Assets
- 10.98
- Total Liabilities
- 4.18
- Total Equity
- 6.8
- Tangible Book Valueper Share Common Eq
- 5.67
- Period
- 2018
- Cashfrom Operating Activities
- -0.35
- Cashfrom Investing Activities
- -0.65
- Cashfrom Financing Activities
- -0.27
- Net Changein Cash
- -1.27
- Period
- 2025-03-31
- Total Revenue
- 18.45
- Selling/ General/ Admin Expenses Total
- 2.89
- Depreciation/ Amortization
- 0.47
- Other Operating Expenses Total
- 6.56
- Total Operating Expense
- 12.38
- Operating Income
- 6.08
- Net Income Before Taxes
- 7.15
- Net Income
- 5.14
- Diluted Normalized EPS
- 4.28
- Period
- 2025-03-31
- Total Assets
- 112.53
- Total Liabilities
- 6.96
- Total Equity
- 105.57
- Tangible Book Valueper Share Common Eq
- 87.95
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 14.82
- Cashfrom Investing Activities
- -1.33
- Cashfrom Financing Activities
- -1.2
- Net Changein Cash
- 12.29
- Period
- 2024-12-31
- Total Revenue
- 14.95
- Selling/ General/ Admin Expenses Total
- 2.89
- Depreciation/ Amortization
- 0.48
- Other Operating Expenses Total
- 3.57
- Total Operating Expense
- 10.22
- Operating Income
- 4.73
- Net Income Before Taxes
- 5.82
- Net Income
- 4.53
- Diluted Normalized EPS
- 3.77
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 16.27
- Selling/ General/ Admin Expenses Total
- 2.89
- Depreciation/ Amortization
- 0.47
- Other Operating Expenses Total
- 3.86
- Total Operating Expense
- 10.93
- Operating Income
- 5.34
- Net Income Before Taxes
- 6.38
- Net Income
- 4.82
- Diluted Normalized EPS
- 4.01
- Period
- 2024-09-30
- Total Assets
- 102.67
- Total Liabilities
- 6.76
- Total Equity
- 95.91
- Tangible Book Valueper Share Common Eq
- 79.9
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 9.61
- Cashfrom Investing Activities
- -1.07
- Cashfrom Financing Activities
- -1.2
- Net Changein Cash
- 7.34
- Period
- 2024-06-30
- Total Revenue
- 13.36
- Selling/ General/ Admin Expenses Total
- 2.68
- Depreciation/ Amortization
- 0.48
- Other Operating Expenses Total
- 3.35
- Total Operating Expense
- 9.32
- Operating Income
- 4.04
- Net Income Before Taxes
- 4.9
- Net Income
- 3.67
- Diluted Normalized EPS
- 3.06
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 16.24
- Selling/ General/ Admin Expenses Total
- 2.57
- Depreciation/ Amortization
- 0.46
- Other Operating Expenses Total
- 4.04
- Total Operating Expense
- 10.7
- Operating Income
- 5.54
- Net Income Before Taxes
- 6.37
- Net Income
- 4.77
- Diluted Normalized EPS
- 3.97
- Period
- 2024-03-31
- Total Assets
- 94.82
- Total Liabilities
- 6.2
- Total Equity
- 88.62
- Tangible Book Valueper Share Common Eq
- 73.83
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 11.62
- Cashfrom Investing Activities
- -1.7
- Cashfrom Financing Activities
- -0.32
- Net Changein Cash
- 9.61
- Period
- 2023-12-31
- Total Revenue
- 13.62
- Selling/ General/ Admin Expenses Total
- 2.52
- Depreciation/ Amortization
- 0.42
- Other Operating Expenses Total
- 3.59
- Total Operating Expense
- 9.57
- Operating Income
- 4.05
- Net Income Before Taxes
- 4.73
- Net Income
- 3.64
- Diluted Normalized EPS
- 3.03
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Prevest Denpro Technical
Moving Average
SMA
- 5 Day471.06
- 10 Day474.61
- 20 Day478.74
- 50 Day484
- 100 Day476.36
- 300 Day528.59
Prevest Denpro Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Poly Medicure
- 2160.65
- -30.3
- -1.38
- 3350
- 1788.05
- 21940.95
- Mallcom (india)
- 1326
- 41.75
- 3.25
- 1780
- 1001
- 831.03
- Prevest Denpro
- 477.85
- 0.7
- 0.15
- 686
- 393.6
- 573.74
- Nureca
- 282.25
- 1.6
- 0.57
- 447
- 198
- 282.25
- One Global Service Provider
- 230.3
- 4.5
- 1.99
- 407.6
- 122.8
- 163.62
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Poly Medicure
- 64.29
- 8.03
- 16.63
- 18.03
- Mallcom (india)
- 21.48
- 2.72
- 19.98
- 9.57
- Prevest Denpro
- 31.09
- 5.35
- 22.1
- 29.75
- Nureca
- 342.78
- 1.45
- 9.56
- 10.5
- One Global Service Provider
- 23.75
- 6.03
- 43.59
- 12.75
Prevest Denpro Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 27-May-25
- Audited Results
- 09-May-25
- Audited Results
- 01-Feb-25
- Quarterly Results
- 11-Nov-24
- Half Yearly Results
- 08-Aug-24
- Quarterly Results & Final Dividend
- 28-May-24
- Audited Results
- 10-May-24
- Audited Results
- 03-Feb-24
- Quarterly Results
- 03-Nov-23
- Half Yearly Results
- 03-Aug-23
- Quarterly Results, Final Dividend & A.G.M.
- Meeting Date
- Announced on
- Purpose
- 06-Sept-24
- 20-Aug-24
- AGM
- 30-Aug-23
- 05-Aug-23
- AGM
- 16-Sept-22
- 10-Aug-22
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 08-Aug-24
- 30-Aug-24
- 30-Aug-24
- 1
- 03-Aug-23
- 23-Aug-23
- 23-Aug-23
- 1


